Appointment of the President of Management Board of TZF Polfa S.A.

Following a formal selection process, the Supervisory Board has appointed Małgorzata Pajączek as President of the Management Board (CEO) of TZF Polfa, bringing to the company her extensive expertise in medicines development, manufacturing, and building national medicines security.

Małgorzata Pajączek, MD PhD is an experienced leader in the pharmaceutical and biotechnology sectors, specialising in biologics, R&D, and public health security. From 2018 to 2026, she served as President of the Management Board (CEO) of Wytwórnia Surowic i Szczepionek BIOMED Sp. z o.o., where she spearheaded the company’s transformation, advanced research and development initiatives, and expanded manufacturing capacity for biologics and therapies of critical importance to public health.

Her professional record includes leading R&D projects and implementing solutions to enhance medicines independence and epidemiological security. She is actively involved in initiatives focused on innovative therapies and medicines of strategic significance to the healthcare system. Professionally, she focuses on building manufacturing expertise in essential medicines and strengthening the role of domestic producers in ensuring continuity of supply and healthcare system resilience.

More information is available on our website: Management and Supervisory Board.